Compound Detail
CHEMBL221062
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL221062 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VYYCUPFQSXZZSA-NTEUORMPSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
249.3
MW (Da)
1.17
ALogP
4
HBA
1
HBD
53.4
PSA (Ų)
0.48
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 8.96
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| 41M | IC50 | = | 1.1 | nM | 8.96 | Cytotoxicity against human 41M cells after 96 hrs by MTT assay | 17315858 |
| ADMET | IC50 | = | 5.0 | nM | 8.3 | Cytotoxicity against human SKBR3 cells after 96 hrs by MTT assay | 17315858 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 1354751 | 10.1021/jm00095a027 | HuT78 | 1 |
| 1354751 | 10.1021/jm00095a027 | MT4 | 1 |
| 17315858 | 10.1021/jm0612618 | 41M | 1 |
| 17315858 | 10.1021/jm0612618 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine